Loading clinical trials...

Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population. | Clinical Trials | Clareo Health

COMPLETED

Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population.

Comparative Observational Study of Residual Gastric Volume Measured by Ultrasound After Preoperative Fasting in a Diabetic Surgical Population Versus a Non-diabetic Surgical Population.

NCT05435157•Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

View on ClinicalTrials.gov

Summary

Comparison of residual gastric volume measure by ultrasounds between diabetic and non-diabetic patients scheduled for elective surgery

Detailed Description

The presence of gastric content increases the risk of aspiration during general anesthesia. Delayed gastric emptying has been described in diabetic patients; for that reason, diabetic patients could have a high risk of aspiration despite adequate fasting. This study aimed to compare ultrasound-guided measurement of residual gastric volume between diabetic and non-diabetic patients scheduled for elective surgery.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•BMI\<40 kg.m-2;
•Age over 18 years;
•American Society of Anesthesiologists' physical status status I-III
•who were to undergo elective surgery and had the ability to understand the rationale of the study and provide informed consent

Exclusion Criteria

•Pregnancy
•Recent upper gastrointestinal bleed (\< 1 month)
•Abnormal anatomy of the upper gastrointestinal tract (such as hiatal hernias and gastric tumors)
•Previous surgical procedures on the esophagus, stomach, or upper abdomen
•Gastroesophageal reflux disease
•Previous use of prokinetics or high doses of opiates.

Locations (1)

IBSAL

Salamanca, Salamanca, Spain

Key Dates

Start Date

March 9, 2022

Primary Completion Date

December 31, 2024

Completion Date

December 31, 2024

Last Updated

May 2, 2025

Enrollment

296

ACTUAL participants

Conditions

Diabetes Mellitus

Genetic Studies of Insulin and Diabetes

NCT00001987

Diabetes MellitusSevere Insulin Resistance

View study

RECRUITINGNA

Feasibility of a Tailored Online Self-compassion Intervention

NCT07051005

Type 1 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 2, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population.

Inclusion Criteria

Exclusion Criteria

Genetic Studies of Insulin and Diabetes

Feasibility of a Tailored Online Self-compassion Intervention

Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Fasted Exercise Training in Type 1 Diabetes (FED-T1D)

Achieving Routine Intervention and Screening for Emotional Health